Global Paliperidone Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Paliperidone Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.
Paliperidone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paliperidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Adolescents are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Paliperidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Paliperidone key companies include Janssen Pharmaceutica, Mylan, Teva and Sun Pharmaceutical, etc. Janssen Pharmaceutica, Mylan, Teva are top 3 players and held % share in total in 2022.
Paliperidone can be divided into 1.5 mg Tablet, 3 mg Tablet, 6 mg Tablet and 9 mg Tablet, etc. 1.5 mg Tablet is the mainstream product in the market, accounting for % share globally in 2022.
Paliperidone is widely used in various fields, such as Adults and Adolescents, etc. Adults provides greatest supports to the Paliperidone industry development. In 2022, global % share of Paliperidone went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paliperidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Janssen Pharmaceutica
Mylan
Teva
Sun Pharmaceutical
Segment by Type
1.5 mg Tablet
3 mg Tablet
6 mg Tablet
9 mg Tablet
Adults
Adolescents
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Paliperidone market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Paliperidone introduction, etc. Paliperidone Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Paliperidone market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Paliperidone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Paliperidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Adolescents are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Paliperidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Paliperidone key companies include Janssen Pharmaceutica, Mylan, Teva and Sun Pharmaceutical, etc. Janssen Pharmaceutica, Mylan, Teva are top 3 players and held % share in total in 2022.
Paliperidone can be divided into 1.5 mg Tablet, 3 mg Tablet, 6 mg Tablet and 9 mg Tablet, etc. 1.5 mg Tablet is the mainstream product in the market, accounting for % share globally in 2022.
Paliperidone is widely used in various fields, such as Adults and Adolescents, etc. Adults provides greatest supports to the Paliperidone industry development. In 2022, global % share of Paliperidone went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paliperidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Janssen Pharmaceutica
Mylan
Teva
Sun Pharmaceutical
Segment by Type
1.5 mg Tablet
3 mg Tablet
6 mg Tablet
9 mg Tablet
Segment by Application
Adults
Adolescents
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Paliperidone market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Paliperidone introduction, etc. Paliperidone Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Paliperidone market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices